2017
DOI: 10.4037/ccn2017308
|View full text |Cite
|
Sign up to set email alerts
|

Reducing Risks Associated With Negative-Pressure Wound Therapy: Strategies for Clinical Practice

Abstract: Negative-pressure wound therapy represents a relatively new strategy for wound management. Significant, life-threatening complications (bleeding, infection, and retained dressing material) have been associated with negative-pressure wound therapy. As a result, the Food and Drug Administration published several warnings to negative-pressure wound therapy users and recommended that clinicians ordering, managing, and/or monitoring negative-pressure wound therapy be aware of the potential complications and be prep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
22
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(23 citation statements)
references
References 42 publications
0
22
0
1
Order By: Relevance
“…Minor complications mostly involve device malfunctions, loss of pressure, and leakage or damage to periwound skin caused by the trac pad. 37,38 Major complications include toxic shock syndrome, 39 bleeding complications, 40 arterial erosion and hemorrhage, 41 empyema, 42 uncon-trolled sepsis, 43 and major bleeding complications due to cardiac rupture. 44 Based on these reports, the United States Food and Drug Administration (FDA) has identified bleeding, infection, and retained dressing material as three potentially lifethreatening complications of NPWT.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Minor complications mostly involve device malfunctions, loss of pressure, and leakage or damage to periwound skin caused by the trac pad. 37,38 Major complications include toxic shock syndrome, 39 bleeding complications, 40 arterial erosion and hemorrhage, 41 empyema, 42 uncon-trolled sepsis, 43 and major bleeding complications due to cardiac rupture. 44 Based on these reports, the United States Food and Drug Administration (FDA) has identified bleeding, infection, and retained dressing material as three potentially lifethreatening complications of NPWT.…”
Section: Discussionmentioning
confidence: 99%
“…44 Based on these reports, the United States Food and Drug Administration (FDA) has identified bleeding, infection, and retained dressing material as three potentially lifethreatening complications of NPWT. 38…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Outra questão muito importante a ser realizada é a capacitação profissional e educação contínua dos profissionais, segundo o autor Pachá et al (2018), a capacitação profissional é também uma forma de cuidado, tanto na prevenção quando no tratamento. Desse modo 2 artigos abordaram acerca da importância da prevenção de lesão por pressão através da educação continuada (Campo et al, 2019;Mattox, 2017).…”
Section: Base De Dadosunclassified